Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

Sprigg, Nikola; Flaherty, Katie; P. Appleton, Jason; Al‐Shahi Salman, Rustam; Bereczki, Dániel; Beridze, Maia; Christensen, Hanne; Ciccone, Alfonso; Collins, Rónán; Członkowska, Anna; A. Dineen, Robert; Duley, Lelia; Egea-Guerrero, J.J.; J. England, Timothy; Krishnan, Kailash; Charlotte Laska, Ann; Kang Law, Zhe; Öztürk, Şerefnur; Pocock, Stuart; Roberts, Ian; Robinson, Thompson; Roffe, Christine; Seiffge, David; Scutt, Polly; Thanabalan, Jegan; J. Werring, David; K. Whynes, David; M. Bath, Philip

doi:10.1016/s0140-6736(18)31033-x

Public

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

Published in The Lancet • May 1, 2018

Authors:

Nikola Sprigg

Katie Flaherty

Jason P. Appleton

Abstract

BACKGROUND: Tranexamic acid can prevent death due to bleeding after trauma and post-partum haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma expansion and improves outcome in adults with stroke due to intracerebral haemorrhage. METHODS: We did an international, randomised pla...

Subject

Tranexamic acid

Medicine

Placebo

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!